Karin A. Ziegler

Karin A. Ziegler

Auto-generated profile, based on publicly available information

Karin A. Ziegler

Institute of Pharmacology and Toxicology, Technical University Munich (TUM), Munich, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2023 in Science
Verified
Journal Article
Closed access
KZKarin A. Ziegler
Karin A. Ziegler
AAAndrea Ahles
Andrea Ahles
ADAnne Dueck
Anne Dueck
DEDena Esfandyari
Dena Esfandyari
PPPauline Pichler
Pauline Pichler
SEStefan Engelhardt
Stefan Engelhardt
Disruption of the physiologic sleep-wake cycle and low melatonin levels frequently accompany cardiac disease, yet the underlying mechanism has remained enigmatic. Immunostaining of sympathetic axons in optically cleared pineal glands from humans and mice with cardiac disease revealed their substantial denervation compared with controls. Spatial, single-cell, nuclear, and bulk RNA sequencing traced this defect back to the superior cervical ganglia (SCG), which responded to cardiac disease with accumulation of inflammatory macrophages, fibrosis, and the selective loss of pineal gland–innervating neurons. Depletion of macrophages in the SCG prevented disease-associated denervation of the pineal gland and restored physiological melatonin secretion. Our data identify the mechanism by which diurnal rhythmicity in cardiac disease is disturbed and suggest a target for therapeutic intervention.

23 May 2025 in Circulation Research
Verified
Journal Article
Closed access
KZKarin A. Ziegler
Karin A. Ziegler
SEStefan Engelhardt
Stefan Engelhardt
DCDaniela Carnevale
Daniela Carnevale
CMCameron S. McAlpine
Cameron S. McAlpine
TGTomasz J. Guzik
Tomasz J. Guzik
FSFilip K. Swirski
Filip K. Swirski
Although the neurocardiac axis is central to cardiovascular homeostasis, its dysregulation drives heart failure and cardiometabolic diseases. This review examines the bidirectional interplay between the autonomic nervous system and the heart, highlighting the role of this interplay in disease progression and its therapeutic potential. The autonomic nervous system modulates cardiac function and vascular tone through its sympathetic and parasympathetic branches. However, in heart failure, chronic sympathetic overdrive and parasympathetic withdrawal exacerbate myocardial remodeling and metabolic dysfunction, both of which are exacerbated by cardiometabolic conditions such as obesity and diabetes. These conditions are increasingly recognized to impair neurocardiac regulation, thereby promoting inflammation and adverse outcomes. An important emerging area concerns neuroimmune control, in which the brain orchestrates systemic inflammation through circuits involving the bone marrow, spleen, and other organs, thereby amplifying cardiovascular damage. This neuroimmune axis integrates peripheral signals to influence immune responses that contribute to disease progression. Lifestyle factors, such as stress, sleep, exercise, and diet, affect autonomic and immune balance and, thus, cardiovascular disease. Therapeutically, targeting neurocardiac and neuroimmune pathways pharmacologically or via neuromodulation (eg, vagal or splenic nerve stimulation) offers promise although the clinical translation of the latter remains challenging. In this review, we synthesize preclinical and clinical data to highlight the neurocardiac axis as a critical nexus in heart failure and cardiometabolic disease. Harnessing neuroimmune and neurocardiac interactions may inform precision approaches to reduce the burden of these conditions.

25 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAntoneta Gavoci
Antoneta Gavoci
AZAnxhela Zhiti
Anxhela Zhiti
MRMichaela Rusková
Michaela Rusková
MMMaria M. Magiera
Maria M. Magiera
MWMengzhe Wang
Mengzhe Wang
MBMonika S. Brill
Monika S. Brill
Developmental remodeling shapes neural circuits via activity-dependent pruning of synapses and axons. Regulation of the cytoskeleton is critical for this process, as microtubule loss via enzymatic severing is an early step of pruning across many circuits and species. However, how microtubule-severing enzymes, such as spastin, are activated in specific neuronal compartments remains unknown. Here, we reveal that polyglutamylation, a post-translational tubulin modification enriched in neurons, plays an instructive role in developmental remodeling by tagging microtubules for severing. Motor neuron-specific gene deletion of enzymes that add or remove tubulin polyglutamylation—TTLL glutamylases vs. CCP deglutamylases—accelerates or delays neuromuscular synapse remodeling in a neurotransmission-dependent manner. This mechanism is not specific to peripheral synapses but also operates in central circuits, e.g., the hippocampus. Thus, tubulin polyglutamylation acts as a cytoskeletal rheostat of remodeling that shapes neuronal morphology and connectivity.

25 March 2025 in Circulation
Verified
Journal Article
Closed access
KZKarin A. Ziegler
Karin A. Ziegler
MZManuel Zeitler
Manuel Zeitler
SMSandro Meunier
Sandro Meunier
ISInga Sinicina
Inga Sinicina
THTim Hasenbein
Tim Hasenbein
SEStefan Engelhardt
Stefan Engelhardt

13 July 2026 in Nature Metabolism
Verified
Journal Article
Open access
GSGitalee Sarker
Gitalee Sarker
EHEmma Haberman
Emma Haberman
ACAnandhakumar Chandran
Anandhakumar Chandran
TMThomas Monfeuga
Thomas Monfeuga
CMCyrielle Maroteau
Cyrielle Maroteau
ADAna I. Domingos
Ana I. Domingos
The regulatory mechanism of leptin’s afferent action in the brain is contingent upon the efferent sympathetic innervation of white and brown adipose tissues. Nonetheless, the peripheral regulation governing the afferent–efferent balance remains ambiguous. Here we show the enriched expression of both leptin receptor ( Lepr ) and β 2 -adrenergic receptor ( Adrb2 ) in perineurial cells that form a barrier around sympathetic ganglia and nerve bundles in adipose tissues, using single-cell RNA sequencing on mouse sympathetic ganglia. Lepr + sympathetic perineurial cells (SPCs) are molecularly similar to endothelial cells. Conditional knockout of Adrb2 in Lepr + cells, including SPCs, predisposes male mice to obesity by lowering energy expenditure and thermogenesis without affecting food intake. Notably, obesity-associated hyperleptinaemia causes apoptosis in SPCs, disrupting the perineurial barrier and concomitant adipose sympathetic neuropathy. This deleterious effect can be reversed by partial reduction of leptin or sympathomimetic β 2 -adrenergic receptor agonism. Clinically, we observed a male-specific synergistic effect of LEPR and ADRB2 polymorphisms on increased body mass index risk in a large European population. We propose that SPCs coordinate the afferent and efferent arms of the neuroendocrine loop of leptin action to regulate energy expenditure and body weight.

11 August 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
GSGitalee Sarker
Gitalee Sarker
EHEmma Haberman
Emma Haberman
ACAnandhakumar Chandran
Anandhakumar Chandran
TMThomas Monfeuga
Thomas Monfeuga
CMCyrielle Maroteau
Cyrielle Maroteau
ADAna I. Domingos
Ana I. Domingos